Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer.
Saved in:
| Title: | Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer. |
|---|---|
| Authors: | Wang, De‐shen1 (AUTHOR), Wang, Zhi‐qiang1 (AUTHOR), Chen, Gong2 (AUTHOR), Peng, Jie‐wen3 (AUTHOR), Wang, Wei4 (AUTHOR), Deng, Yan‐hong5 (AUTHOR), Wang, Feng‐hua1 (AUTHOR), Zhang, Jian‐wei5 (AUTHOR), Liang, Han‐lin3 (AUTHOR), Feng, Fen4 (AUTHOR), Xie, Chuan‐bo6 (AUTHOR), Ren, Chao1 (AUTHOR), Jin, Ying1 (AUTHOR), Shi, Si‐mei1 (AUTHOR), Fan, Wen‐hua2 (AUTHOR), Lu, Zhen‐hai2 (AUTHOR), Ding, Pei‐rong2 (AUTHOR), Wang, Feng1 (AUTHOR), Xu, Rui‐hua1 (AUTHOR) xurh@sysucc.org.cn, Li, Yu‐hong1 (AUTHOR) liyh@sysucc.org.cn |
| Source: | Cancer Medicine. Jan2020, Vol. 9 Issue 1, p151-159. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
